Please use this identifier to cite or link to this item:
http://hdl.handle.net/11690/1788| Authors: | Furtado, Remo H. M. Berwanger, Otavio. Fonseca, Henrique A. Corrêa, Thiago D. Ferraz, Leonardo R. Lapa, Maura G. Zampieri, Fernando G. Veiga, Viviane C. Azevedo, Luciano C. P. Rosa, Regis G. Lopes, Renato D. Avezum, Alvaro Manoel, Airton L. O. Piza, Felipe M. T. Martins, Priscilla A. Lisboa, Thiago Pereira, Adriano J. Olivato, Guilherme B. Dantas, Vicente C. S. Milan, Eveline P. Gebara, Otavio C. E. Amazonas, Roberto B. Oliveira, Monalisa B. Soares, Ronaldo V. P. Moia, Diogo D. F. Piano, Luciana P. A. Castilho, Kleber Momesso, Roberta G. R. A. P. Schettino, Guilherme P. P. Rizzo, Luiz Vicente Serpa Neto, Ary Machado, Flávia R . Cavalcanti, Alexandre B. |
| Title: | Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial |
| Keywords: | COVID-19;Azithromycin |
| Issue Date: | 2020 |
| Publisher: | Elsevier |
| Citation: | FURTADO, R. H. M. et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet, v. 396, n. 10256, p. 959-967, 2018. Disponível em: http://hdl.handle.net/11690/1788. Acesso em: 09 jul. 2021. |
| Appears in Collections: | Artigo de Periódico (PPGSDH) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Azithromycin in addition to standard of care_LANCET.pdf | Open Access | 405 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.